Literature DB >> 9306944

Giant cells in pigmented villo nodular synovitis express an osteoclast phenotype.

S D Neale1, R Kristelly, R Gundle, J M Quinn, N A Athanasou.   

Abstract

AIM: To determine the cytochemical and functional phenotype of multinucleated giant cells in pigmented villo nodular synovitis (PVNS).
METHODS: Giant cells isolated from a patient with PVNS of the knee were assessed for a number of markers used to distinguish osteoclasts from macrophages/ macrophage polykaryons: evidence of tartrate resistant acid phosphatase (TRAP) activity; expression of CD11b, CD14, CD51, and calcitonin receptors; and the ability of the giant cells to carry out lacunar resorption.
RESULTS: Isolated giant cells expressed an osteoclast antigenic phenotype (positive for CD51, negative for CD11b and CD14) and were TRAP and calcitonin receptor positive. They also showed functional evidence of osteoclast differentiation, producing numerous lacunar bone resorption pits on bone slices in short term culture.
CONCLUSIONS: The giant cells in this case of PVNS express all the phenotypical features of osteoclasts including the ability to carry out lacunar resorption. This may account for the bone destruction associated with this aggressive synovial lesion.

Entities:  

Mesh:

Year:  1997        PMID: 9306944      PMCID: PMC500074          DOI: 10.1136/jcp.50.7.605

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  17 in total

1.  New sites of cellular vitronectin receptor immunoreactivity detected with osteoclast-reacting monoclonal antibodies 13C2 and 23C6.

Authors:  N A Athanasou; J Quinn; M A Horton; J O McGee
Journal:  Bone Miner       Date:  1990-01

2.  Immunophenotypic differences between osteoclasts and macrophage polykaryons: immunohistological distinction and implications for osteoclast ontogeny and function.

Authors:  N A Athanasou; J Quinn
Journal:  J Clin Pathol       Date:  1990-12       Impact factor: 3.411

3.  Abundant calcitonin receptors in isolated rat osteoclasts. Biochemical and autoradiographic characterization.

Authors:  G C Nicholson; J M Moseley; P M Sexton; F A Mendelsohn; T J Martin
Journal:  J Clin Invest       Date:  1986-08       Impact factor: 14.808

4.  Pigmented villonodular synovitis.

Authors:  F Flandry; J C Hughston
Journal:  J Bone Joint Surg Am       Date:  1987-07       Impact factor: 5.284

5.  Human osteoclast formation and bone resorption by monocytes and synovial macrophages in rheumatoid arthritis.

Authors:  Y Fujikawa; A Sabokbar; S Neale; N A Athanasou
Journal:  Ann Rheum Dis       Date:  1996-11       Impact factor: 19.103

6.  Monoclonal antibodies to osteoclastomas (giant cell bone tumors): definition of osteoclast-specific cellular antigens.

Authors:  M A Horton; D Lewis; K McNulty; J A Pringle; T J Chambers
Journal:  Cancer Res       Date:  1985-11       Impact factor: 12.701

7.  Cytogenetic findings and biologic behavior of giant cell tumors of bone.

Authors:  J A Bridge; J R Neff; P S Bhatia; W G Sanger; M D Murphey
Journal:  Cancer       Date:  1990-06-15       Impact factor: 6.860

8.  The multinucleate cells in giant cell granulomas of the jaw are osteoclasts.

Authors:  A M Flanagan; B Nui; S M Tinkler; M A Horton; D M Williams; T J Chambers
Journal:  Cancer       Date:  1988-09-15       Impact factor: 6.860

9.  Giant cell tumor of tendon sheath and pigmented villonodular synovitis: an ultrastructural study.

Authors:  A Alguacil-Garcia; K K Unni; J R Goellner
Journal:  Am J Clin Pathol       Date:  1978-01       Impact factor: 2.493

10.  The origin and nature of stromal osteoclast-like multinucleated giant cells in breast carcinoma: implications for tumour osteolysis and macrophage biology.

Authors:  N A Athanasou; C A Wells; J Quinn; D P Ferguson; A Heryet; J O McGee
Journal:  Br J Cancer       Date:  1989-04       Impact factor: 7.640

View more
  8 in total

1.  Mature and activated osteoclasts exist in the synovium of rapidly destructive coxarthrosis.

Authors:  Kenji Ogawa; Masaaki Mawatari; Mitsunori Komine; Masamori Shigematsu; Masaru Kitajima; Akiko Kukita; Takao Hotokebuchi
Journal:  J Bone Miner Metab       Date:  2007-10-25       Impact factor: 2.626

2.  Stimulation of osteoclast formation by inflammatory synovial fluid.

Authors:  Iannis E Adamopoulos; Lynett Danks; Ichiro Itonaga; Rachel M Locklin; Afsie Sabokbar; David J P Ferguson; Nicholas A Athanasou
Journal:  Virchows Arch       Date:  2006-04-21       Impact factor: 4.064

3.  Magnetic resonance imaging features of fibromas and giant cell tumors of the tendon sheath: differential diagnosis.

Authors:  Yuxi Ge; Gang Guo; Yaqian You; Yunzhi Li; Yinghua Xuan; Zhe-Wu Jin; Gen Yan
Journal:  Eur Radiol       Date:  2019-04-30       Impact factor: 5.315

4.  Paracrine-mediated differentiation and activation of human haematopoietic osteoclast precursor cells by skin and gingival fibroblasts.

Authors:  J Costa-Rodrigues; M H Fernandes
Journal:  Cell Prolif       Date:  2011-06       Impact factor: 6.831

5.  Evaluation of giant cell tumors by diffusion weighted imaging-fractional ADC analysis.

Authors:  Oganes Ashikyan; M Chalian; D Moore; Y Xi; P Pezeshk; A Chhabra
Journal:  Skeletal Radiol       Date:  2019-04-19       Impact factor: 2.199

6.  Intraarticular adalimumab in a patient with pigmented villonodular synovitis.

Authors:  Senol Kobak
Journal:  Rheumatol Int       Date:  2009-10-10       Impact factor: 2.631

7.  Tenosynovial giant cell tumour (pigmented villonodular synovitis-)-like changes in periprosthetic interface membranes.

Authors:  Stephan Söder; Stefan Sesselmann; Thomas Aigner; Stephan Oehler; Abbas Agaimy
Journal:  Virchows Arch       Date:  2015-11-09       Impact factor: 4.064

8.  Surgical treatment for diffused-type giant cell tumor (pigmented villonodular synovitis) about the ankle joint.

Authors:  Xingchen Li; Yang Xu; Yuan Zhu; Xiangyang Xu
Journal:  BMC Musculoskelet Disord       Date:  2017-11-14       Impact factor: 2.362

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.